Stocklytics Platform
Asset logo for symbol DRMA
Dermata Therapeutics, Inc. Common Stock
DRMA53
$1.97arrow_drop_down12.44%-$0.28
Penny Stock
Asset logo for symbol DRMA
DRMA53

$1.97

arrow_drop_down12.44%

Performance History

Chart placeholder
Key Stats
Open$2.28
Prev. Close$2.25
EPS-18.73
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$2.71M
PE Ratio-
LOWHIGH
Day Range1.93
2.30
52 Week Range0.23
6.16
Ratios
Revenue-
EBITDA Margin %-
EPS-18.73

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Dermata Therapeutics, Inc. Common Stock (DRMA)

The Dermata Therapeutics, Inc. Common Stock (DRMA) is a pharmaceutical company that specializes in the development and commercialization of innovative dermatological therapies. With a focus on addressing unmet needs in the field of dermatology, Dermata Therapeutics is dedicated to improving the lives of patients suffering from various skin conditions.
The stock price history of Dermata Therapeutics, Inc. Common Stock (DRMA) has displayed fluctuations over the years, influenced by market conditions and the company's performance. Investors should carefully analyze the historical data and market trends before making any investment decisions.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Gerald T. Proehl
Headquarters
San Diego
Employees
8
Exchange
NASDAQ
add Dermata Therapeutics, Inc. Common Stock to watchlist

Keep an eye on Dermata Therapeutics, Inc. Common Stock

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Dermata Therapeutics, Inc. Common Stock's (DRMA) price per share?

The current price per share for Dermata Therapeutics, Inc. Common Stock (DRMA) is $1.98. The stock has seen a price change of -$0.27 recently, indicating a -12% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Dermata Therapeutics, Inc. Common Stock (DRMA)?

For Dermata Therapeutics, Inc. Common Stock (DRMA), the 52-week high is $6.16, which is 211.36% from the current price. The 52-week low is $0.23, the current price is 753.45% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Dermata Therapeutics, Inc. Common Stock (DRMA) a growth stock?

Dermata Therapeutics, Inc. Common Stock (DRMA) has shown an average price growth of 0.41% over the past three years. It has received a score of 37 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Dermata Therapeutics, Inc. Common Stock as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Dermata Therapeutics, Inc. Common Stock (DRMA) stock price performance year to date (YTD)?

As of the latest data, Dermata Therapeutics, Inc. Common Stock (DRMA) has a year-to-date price change of -77.63%. Over the past month, the stock has experienced a price change of -7.91%. Over the last three months, the change has been -20.16%. Over the past six months, the figure is -65.09%.
help

Is Dermata Therapeutics, Inc. Common Stock (DRMA) a profitable company?

Dermata Therapeutics, Inc. Common Stock (DRMA) has a net income of -$7.79M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$8.04M. Furthermore, the EBITDA is $0.
help

What is the market capitalization of Dermata Therapeutics, Inc. Common Stock (DRMA)?

Dermata Therapeutics, Inc. Common Stock (DRMA) has a market capitalization of $2.71M. The average daily trading volume is 2.64M, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media